journal article·2024-01-10

Naloxone-AuNPs@ZIF-8-Based Impedimetric Sensor Platform for Ultrasensitive Detection of Fentanyl and Fabrication of Fen-Track Prototype for Real-Field Analysis

Anirban Paul, Ivneet Kaur Banga, Sriram Muthukumar, Shalini Prasad

Publisher page

Abstract

Opioids are considered to be a global threat, and we are facing the worst opioid crisis of the decade. Synthetic opioids like fentanyl are highly potent and deadly toward human body, and hence its detection is an inevitable requirement globally. Naloxone is known for its antagonist property toward fentanyl, and we performed computational simulations to find their interactions and use this principle to build the first of a kind impedimetric sensor device, transduced by 3D-ZIF-8 with in situ encapsulated naloxone-gold nanoparticles. The probe is synthesized using a unique encapsulation strategy, thoroughly characterized by various physicochemical and microscopic tools. The sensor is highly selective toward fentanyl and can detect fentanyl up to 100 ppm in a synthetic sample. A prototype device is also built based on the synthetic calibration and applied to the spiked urine sample, and the performance is evaluated using statistical and machine learning tools.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Chemical Sensor Technologies · Mass Spectrometry Techniques and Applications · Gas Sensing Nanomaterials and Sensors

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering, University of Texas at Dallas, Richardson, Texas 75080, United States

EnLiSense LLC, 1813 Audubon Pondway, Allen, Texas 75013, United States

References (27)

Show source-provided references
1. 10.1097/MLR.000000000000062510.1097/MLR.0000000000000625 ↗
2. 10.1038/d41586-019-02686-210.1038/d41586-019-02686-2 ↗
3. 10.1016/B978-0-323-39006-4.00034-X10.1016/B978-0-323-39006-4.00034-X ↗
4. 10.2165/00003495-199753010-0001110.2165/00003495-199753010-00011 ↗
5. 10.5580/dea10.5580/dea ↗
6. 10.1016/j.cbpa.2005.07.00110.1016/j.cbpa.2005.07.001 ↗
7. 10.1016/0379-0738(89)90117-510.1016/0379-0738(89)90117-5 ↗
8. Al-Salman H. N. K. · Int. J. Green Pharm. · 2018 · 12 · 216
9. 10.1186/s13643-019-1048-y10.1186/s13643-019-1048-y ↗
10. 10.1016/j.forc.2017.04.00110.1016/j.forc.2017.04.001 ↗
11. 10.1111/dar.1300410.1111/dar.13004 ↗
12. 10.1021/acs.analchem.2c0521110.1021/acs.analchem.2c05211 ↗
13. 10.1186/s40163-016-0062-910.1186/s40163-016-0062-9 ↗
14. 10.1021/acs.analchem.1c0072310.1021/acs.analchem.1c00723 ↗
15. 10.1016/j.trac.2022.11662310.1016/j.trac.2022.116623 ↗
16. 10.1016/j.ssnmr.2020.10169710.1016/j.ssnmr.2020.101697 ↗
17. 10.1149/1945-7111/abba8f10.1149/1945-7111/abba8f ↗
18. 10.1021/acs.analchem.2c0061110.1021/acs.analchem.2c00611 ↗
19. 10.1016/j.bios.2020.11294010.1016/j.bios.2020.112940 ↗
20. 10.1021/acsomega.2c0073710.1021/acsomega.2c00737 ↗
21. 10.1021/acsanm.8b0074810.1021/acsanm.8b00748 ↗
22. 10.1021/acsomega.8b0196810.1021/acsomega.8b01968 ↗
23. 10.1021/acsami.1c0228310.1021/acsami.1c02283 ↗
24. 10.1039/D1RA03093K10.1039/D1RA03093K ↗
25. 10.14356/kona.202001110.14356/kona.2020011 ↗
26. 10.1039/C7RA09794H10.1039/C7RA09794H ↗
27. 10.1039/C5TA03979G10.1039/C5TA03979G ↗